13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-13, with 69 holding rows worth $1,088,301,000.
- Accession
- 0001144204-19-039265
- Filer
- CIK 1631134
- Filed
- 2019-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 163 entries on the cover page, a total value of $1,088,301,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,088,301,000 with VALUE read as thousands by filing date, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerCrestline Management, LP028-14917
- included managerBlackstone Alternative Asset Management L.P.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,099,824 | $126,645,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 5,208,305 | $100,989,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 3,100,560 | $85,513,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 2,038,208 | $67,648,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 4,749,623 | $53,718,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 481,270 | $49,272,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,104,278 | $48,125,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 2,093,221 | $46,260,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 2,521,856 | $37,777,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 933,640 | $35,348,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 1,729,352 | $34,622,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,961,039 | $28,729,000 | thousands by filing date | |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $24,912,000 | thousands by filing date | |
| NUCANA PLC | 67022C106 | ADR | 2,266,666 | $23,528,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 368,903 | $16,601,000 | thousands by filing date | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 323,697 | $16,521,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 84,433 | $14,136,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 155,860 | $13,159,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 922,700 | $12,493,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 1,630,221 | $12,178,000 | thousands by filing date | |
| ITERUM THERAPEUTICS PLC SHS NEW | G6333L101 | Stock | 1,726,514 | $11,878,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 690,199 | $11,858,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 617,185 | $11,474,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,261,384 | $10,911,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 115,536 | $10,901,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 241,043 | $9,902,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 550,443 | $9,341,000 | thousands by filing date | |
| Morphosys | D55040105 | COM | 96,135 | $9,231,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 50,301 | $9,225,000 | thousands by filing date | |
| AMGEN INC | 031162950 | COM | 50,000 | $9,214,000 | thousands by filing date | put |
| ALLERGAN PLC | G0177J908 | COM | 50,000 | $8,372,000 | thousands by filing date | call |
| Bristol-Myers Squibb Company | 110122108 | COM | 173,849 | $7,884,000 | thousands by filing date | |
| ENTASIS THERAPEUTICS HLDGS I | 293614103 | COM | 1,180,178 | $7,612,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 583,309 | $7,279,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 84,896 | $7,272,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 659,882 | $6,309,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 69,612 | $5,914,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 574,972 | $5,232,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 365,469 | $5,113,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 2,204,202 | $4,540,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122908 | CALL | 100,000 | $4,534,000 | thousands by filing date | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,911,573 | $4,186,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 155,576 | $4,159,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 188,057 | $4,137,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 848,356 | $4,106,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 50,000 | $3,908,000 | thousands by filing date | call |
| OTONOMY INC | 68906L105 | COM | 1,337,568 | $3,679,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 281,857 | $3,103,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 1,115,810 | $2,655,000 | thousands by filing date | |
| XBIOTECH INC | 98400H102 | COM | 331,811 | $2,515,000 | thousands by filing date | |
| ZOGENIX INC | 98978L904 | CALL | 50,000 | $2,389,000 | thousands by filing date | call |
| INTRA CELLULAR THERAPIES INC | 46116X901 | CALL | 175,000 | $2,271,000 | thousands by filing date | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 242,729 | $2,260,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T951 | PUT | 100,100 | $2,258,000 | thousands by filing date | put |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 187,059 | $2,225,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 28,911 | $2,103,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 529,839 | $2,066,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 27,792 | $2,017,000 | thousands by filing date | |
| RVL PHARMACEUTICALS PLC | G6S41R101 | COM | 525,198 | $1,996,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 297,250 | $1,897,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 125,303 | $1,864,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 125,955 | $1,635,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 426,400 | $1,616,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 194,036 | $1,488,000 | thousands by filing date | |
| FORTY SEVEN INC | 34983P104 | COM | 118,803 | $1,259,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 49,580 | $1,256,000 | thousands by filing date | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 142,004 | $1,170,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 65,780 | $1,059,000 | thousands by filing date | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 142,635 | $854,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-19-039265 | this filing | 2019-08-13 | acceptance time not in the bulk data set |